Myriad Genetics to Showcase Innovations at Major Conferences

Author: Dylan Bailey Updated: 08-27-2025 04:22 PM

Myriad Genetics to Showcase Innovations at Upcoming Conferences

Myriad Genetics, Inc. (NASDAQ: MYGN), recognized as a leader in molecular diagnostic testing and precision medicine, is gearing up to take part in two significant healthcare conferences. This platform will allow Myriad to share valuable insights and encourage discussions around the latest advancements in its offerings.

Details of the Conferences

The Wells Fargo Healthcare Conference

Attendees can look forward to a fireside chat featuring Myriad's management at the Wells Fargo Healthcare Conference. This event is scheduled for Thursday. It's an excellent opportunity for investors to gain firsthand knowledge about the company's vision and direction in the healthcare landscape.

The Morgan Stanley Annual Global Healthcare Conference

Additionally, Myriad Genetics will be present at the Morgan Stanley Annual Global Healthcare Conference, where a conversation about their innovative approaches to precision medicine will take center stage. This fireside chat will occur on Wednesday, facilitating knowledge-sharing regarding Myriad's strategic growth and development.

Access to Presentations

For those unable to attend these events, Myriad Genetics will provide links to both live webcast presentations, allowing a broader audience to stay informed about the latest from the company. Investors and interested parties can find archived versions for later viewing, ensuring access to essential updates from Myriad.

About Myriad Genetics

Myriad Genetics is dedicated to advancing health and well-being through its groundbreaking molecular diagnostic testing and precision medicine solutions. The company focuses on developing and offering tests that not only assess the risk of disease but also guide treatment decisions across diverse medical fields. Their commitment to improving patient care and decreasing healthcare costs has made them a cornerstone in the sector.

Company Contacts

Investor Contact

If you wish to reach out for investor relations, please contact Matt Scalo at (801) 584-3532 or email at IR@myriad.com.

Media Contact

For media inquiries, please connect with Kate Schraml at (224) 875-4493 or via email at PR@myriad.com.

Frequently Asked Questions

What is Myriad Genetics known for?

Myriad Genetics is renowned for its expertise in molecular diagnostics and precision medicine, offering innovative tests that improve patient care.

When will Myriad be participating in the conferences?

Myriad will be present at the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley Annual Global Healthcare Conference on September 10.

How can investors access the presentations?

Investors can access live and archived webcasts of the presentations through the Myriad Genetics investor relations page.

What impact does Myriad's testing have on patient care?

The tests developed by Myriad help assess disease risk and guide treatment options, thereby significantly enhancing patient care while reducing costs.

Who should I contact for more inquiries about Myriad?

For inquiries related to investors, contact Matt Scalo. For media inquiries, reach out to Kate Schraml.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.